NYSE:BAX - Baxter International Stock Price, News, & Analysis

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International declared a quarterly dividend on Tuesday, February 19th. Investors of record on Friday, March 1st will be given a dividend of $0.19 per share on Monday, April 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.03%. The ex-dividend date is Thursday, February 28th. View Baxter International's Dividend History.

Baxter International announced that its Board of Directors has authorized a share buyback program on Tuesday, November 13th 2018, which allows the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy up to 6.1% of its shares through open market purchases. Shares repurchase programs are often an indication that the company's leadership believes its stock is undervalued.

Baxter International Inc (NYSE:BAX) issued its earnings results on Thursday, January, 31st. The medical instruments supplier reported $0.78 earnings per share for the quarter, topping the consensus estimate of $0.73 by $0.05. The medical instruments supplier had revenue of $2.84 billion for the quarter, compared to the consensus estimate of $2.80 billion. Baxter International had a net margin of 14.60% and a return on equity of 18.46%. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, April 25th 2019. View Earnings Estimates for Baxter International.

Baxter International issued an update on its FY19 earnings guidance on Thursday, January, 31st. The company provided earnings per share (EPS) guidance of $3.22-3.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.27. The company issued revenue guidance of ~$11.1-11.2 billion, compared to the consensus revenue estimate of $11.37 billion.Baxter International also updated its FY 2019 guidance to $3.22-3.30 EPS.

16 analysts have issued 12-month price objectives for Baxter International's shares. Their forecasts range from $70.00 to $85.00. On average, they anticipate Baxter International's share price to reach $76.5625 in the next twelve months. This suggests a possible upside of 3.3% from the stock's current price. View Analyst Price Targets for Baxter International.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 3 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

News stories about BAX stock have trended neutral on Wednesday, InfoTrie reports. The research group scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Baxter International earned a news sentiment score of 0.3 on InfoTrie's scale. They also assigned media headlines about the medical instruments supplier a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the near term.

Some companies that are related to Baxter International include 3M (MMM), Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), DexCom (DXCM), Hill-Rom (HRC), Insulet (PODD), Penumbra (PEN), ICU Medical (ICUI), Novocure (NVCR) and Globus Medical (GMED).

Baxter International's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.29%), Third Point LLC (5.26%), Northern Trust Corp (1.62%), Geode Capital Management LLC (1.21%), Harris Associates L P (1.05%) and Standard Life Aberdeen plc (0.98%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Third Point LLC, Two Sigma Advisers LP, APG Asset Management N.V., Harris Associates L P, Canada Pension Plan Investment Board, BlackRock Inc., Standard Life Aberdeen plc and Smith Asset Management Group LP. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was acquired by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, State of Tennessee Treasury Department, California Public Employees Retirement System, Mackenzie Financial Corp, State of New Jersey Common Pension Fund D, Eaton Vance Management, Mawer Investment Management Ltd. and Bessemer Group Inc.. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $74.13.

Baxter International has a market capitalization of $39.45 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

The official website for Baxter International is http://www.baxter.com.

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]